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ABSTRACT 
Sildenafil is one of the most commonly used drugs for sexual dysfunction or to increase libido, and it regulates 
endothelial nitric oxide synthase enzyme via selective phosphodiesterase-V inhibition. Sildenafil can be easily obtained 
without a medical indication or prescription yet it is not considered as a completely safe medication. Hemoptysis and 
hemorrhagic stroke are some important adverse effects of sildenafil. The case of the current report was a 67-year-old 
diabetic patient with simultaneous anterior and posterior segment hemorrhage after the use of 100 mg sildenafil citrate. 
Anterior chamber clearance and pars plana vitrectomy were performed for the patient because the hyphema and 
vitreous hemorrhage did not resolve during the follow-up period. There are very limited data available in the literature 
suggesting an increase in the risk of hyphema or vitreous hemorrhage due to the use of sildenafil. This is the first report 
that reveals the bleeding effect of sildenafil use in a patient with type 2 diabetes. 
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INTRODUCTION
Sildenafil citrate is a highly selective phosphodiesterase-V 
inhibitor, which regulates the function of endothelial 
nitric oxide synthase enzyme [1]. It directly effects the 
vessels of the corpus cavernosum and is one of the most 
commonly used drugs for the treatment of sexual 
dysfunction and to increase libido and sexual 
performance [2, 3]. Sildenafil can be easily obtained with 
and without a prescription and is mostly used without 
medical supervision. Flushing, headache, and dizziness 
are the most prevalent side-effects of sildenafil and 
hemoptysis, and hemorrhagic stroke is one of the other 
important adverse effects [4-6]. The current study 
reports of simultaneous anterior and posterior segment 
hemorrhage due to the use of sildenafil in a patient with 
type 2 diabetes.  
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CASE REPORT 
The case was a 67-year-old male patient with type 2 
diabetes mellitus, who had complaints of sudden 
decreased vision in the right eye since the morning of 
referral. Corrected distance visual acuity in the right eye 
was hand motion and in the left eye, 20/40. Examination 
of the right eye revealed grade I hyphema, normal 
intraocular pressure, and normal appearance of iris 
tissue and posterior chamber intraocular lens, although 
the posterior segment was not illuminated. In ocular 
ultrasonography, the retina was normal yet the vitreous 
cavity was seen to be hyperechoic with high gain and 
preoccupied vitreous hemorrhage. In the left eye, there 
were hard exudates and dot-blot hemorrhages 
throughout the retina. In examinations of the left eye, 
optical coherence tomography revealed macular edema 
and the fluorescein angiogram revealed macular edema, 
microaneurysms, and focal leakage of vessels without 
any neovascularization. The patient stated that he used 
100 mg of sildenafil citrate (Viagra; Pfizer, Istanbul, 
Turkey) the previous night for sexual stimulation and 
visual acuity of the right eye was good until this morning. 
The patient was asked about his medical history and drug 
use, and he reported that he had type 2 diabetes mellitus 
only and was only using insulin. The patient also stated 
that he had not received any other ocular treatment, 
such as retinal laser or intravitreal injection. The patient 
had worked regularly in the same job for the last five 
years and there were no important stressor factors in his 
life. An anterior segment photograph of the right eye was 
taken (Fig 1) and informed written consent was obtained 
for the academic use of the photograph. 
 
 
Figure 1: Anterior Segment Photograph of the Right Eye; Hyphema and the Red Reflex of the Intraocular Lens of the Vitreous Hemorrhage. 
 
Figure 2: Intra-retinal Hemorrhages, Hard Exudates and Laser Scar can be shown in the First Postoperative Week Colored Fundus Photograph and 
Optical Coherence Tomography Image of the Right Eye 
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Therapy was firstly initiated with bed rest with the head 
in an upright position, 0.5% loteprednol etabonate 
ophthalmic suspension (Lotemax; Bausch & Lomb 
Pharmaceuticals, New Jersey, USA) four times in a day, 
and 1% tropicamide eye drop (Tropamid 1% Forte; Bilim 
İlaç Sanayi ve Ticaret AŞ, İstanbul, Turkey) two times a 
day. Anterior chamber clearance and pars plana 
vitrectomy were planned for the patient because the 
hyphema and vitreous hemorrhage did not resolve 
during the four weeks of follow-up. In the preoperative 
tests, the complete blood count and coagulation tests 
were determined to be completely normal and no 
disease other than type 2 diabetes mellitus was found in 
the internal medicine consultation. Pars plana vitrectomy 
was performed after one month and final corrected 
distance visual acuity increased to 20/40 during the first 
postoperative week. Intra-retinal hemorrhages, hard 
exudates, and laser photocoagulation scars were seen in 
colored fundus photograph and irregularities in retinal 
layers were shown in the optical coherence tomography 
image (Fig 2). 
DISCUSSION 
In diabetic retinopathy, angiogenic mediators released 
from the ischemic retina cause fibro-vascular 
proliferation and the formation of neovascularization in 
the anterior (neovascularization of the iris) and posterior 
segments (neovascularization at the disc and 
neovascularization elsewhere) of the globe [7]. 
Fibrous component contraction can increase the 
tendency of these abnormal neovascular structures, 
leading to loss of vision due to bleeding in the anterior 
(hyphema) and posterior segments (vitreous 
hemorrhage) [8]. According to recent case reports, drug-
induced intraocular hemorrhages are related to several 
drugs, such as aspirin, warfarin, dabigatran, and ginkgo 
biloba [9-12]. 
A number of articles have reported on blurred vision, 
color vision defects, retinal hemorrhage, and non-
arteritic/arteritic ischemic optic neuropathy, as ocular 
side effects of sildenafil [13-16]. To the best of the 
author’s knowledge, this is the first report that 
mentioned intraocular hemorrhage due to the use of 
sildenafil in a patient with type 2 diabetes. 
There have been numerous reports of intracerebral 
hemorrhage related to the use of sildenafil [17-19]. It is 
thought that the nitric oxide-cyclic guanosine 
monophosphate pathway, induced by inhibition of 
phosphodiesterase-V, leads to cerebral vasodilatation 
and increases blood flow. This mechanism increases the 
risk of intracranial hemorrhage [17]. The effects of 
sildenafil are not limited to vessels in the corpus 
cavernosum and central nervous system. Numerous 
symptoms, such as hemoptysis, purpuric dermatosis, 
dizziness, and stuffiness are related to the effects of 
sildenafil use on the lungs, skin, ear, and nose, 
respectively [4, 5, 20]. 
Sildenafil also has a vasodilator effect on the choroid and 
increases the volume of choroidal blood flow [21]. Koksal 
et al. [22] reported an increment in blood flow in both 
the ophthalmic and short posterior ciliary arteries after 
the use of sildenafil. When considering the combination 
of the effects of the presence of diabetic retinopathy and 
sildenafil use, the risk of intraocular hemorrhage is very 
high.  
Hyperglycemia causes loss of pericyte and thickening in 
basement membrane of retinal blood vessels while 
proliferative stage aberrant angiogenesis of retinal blood 
vessels results in vascular leakage, fibrovascular tissue 
formation, and vitreous hemorrhage [23]. The walls of 
abnormal neovascular structures are more sensitive to an 
increase of ocular blood flow, and bleed easily, triggered 
by the use of sildenafil. Generalized retinal ischemia and 
proliferative factors released from the retina, maintain 
the continuity of this pathophysiological course [24]. 
CONCLUSION  
The current case was a diabetic patient with unilateral 
hyphema and vitreous hemorrhage, who used sildenafil. 
There is no definitive evidence to confirm that the 
hemorrhage in this case was caused by sildenafil itself. 
Nevertheless, it can be hypothesized that the bleeding 
was related to sildenafil due to the former described 
mechanisms. To the best of the author’s knowledge, this 
is the first report of the development of hyphema and 
vitreous hemorrhage during the use of sildenafil in 
patients with type 2 diabetes. It can be speculated that 
the use of sildenafil may increase the risk of hyphema 
and/or vitreous hemorrhage in a patient with diabetes. 
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